Objectives-To characterise the cytoplasmic staining patterns identified by indirect immunofluorescence (IF) of human epithelial (HEp-2) cells and the antigens recognised using additional serological techniques. To define the disease associations of anticytoplasmic antibodies. Methods-Sera from 1173 patients were screened for cytoplasmic IF staining on HEp-2 cells and the patterns characterised. The presence of antimitochondrial antibodies (AMA) was evaluated by a sensitive anti-pyruvate dehydrogenase complex enzyme linked immunosorbent assay (ELISA) (IgG) and by immunoblotting. Detection of antibodies to extractable nuclear antigens (ENA) was performed by double immunodiffusion and the presence of anti-ribosomal P antibodies was determined by immunoblotting. Results-Cytoplasmic IF staining was demonstrated in 75 sera (6-4%). Six different patterns were recognised: coarse granular filamentous speckles (AMA, n = 9); condensed large speckles (anti-golgi apparatus antibodies, n = 3); cytoskeletal (n = 9); centriolar (n = 4); diffuse coarse speckles (n = 33); and fine speckles (n= 17). Of the nine sera with an AMA pattern, the presence of these antibodies was confirmed in seven by the ELISA (n=6) and on immunoblotting (n= 7). One of the seven patients had primary biliary cirrhosis, and two had scleroderma. Two patients with anti-golgi antibodies had rheumatoid arthritis and two with anticentriolar antibodies had scleroderma. Of 33 sera that had cytoplasmic staining and were ANA negative, three were positive for anti-Ro and two were positive for anti-Jo-I antibodies. Conclusions-In general, defined cytoplasmic IF patterns have no specific disease associations. However, the finding of cytoplasmic fluorescence should not be ignored, as it may indicate the presence of antibodies to ENA in the absence of nuclear staining.
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IMMUNODIFFUSION
Autoantibodies to ENA were detected in 10 of the sera with anticytoplasmic antibodies, five of which had a diffuse coarse speckled pattern. Five had anti-Ro (SS-A) antibodies, four had anti-Jo-1 antibodies and another had anti-U1 ribonucleoprotein (RNP) antibodies. Of the five sera that had anti-Ro antibodies, one also had anti-La antibodies and another had both AMA and anti-La antibodies. Five of the patients who had autoantibodies to ENA (anti-Ro, n = 3; anti-Jo-1, n = 2) were ANA negative.
PDHC ELISA
Of the nine sera with AMA IF pattern, six had antibodies detected by the sensitive anti-PDHC ELISA (IgG). Figure 2 shows group.bmj.com on May 3, 2017 -Published by http://ard.bmj.com/ Downloaded from our patients, some of whom had SLE. This may have resulted from their relatively low prevalence which varies between 5 and 20% of patients with SLE.23 24 Furthermore, the antibody titre may vary with time25 and is higher in those patients with active disease26 a feature not necessarily present in our patients.
In conclusion, although, in general, anticytoplasmic antibodies are not disease specific, certain characteristic patterns on IF are of more diagnostic help than others. Furthermore, a negative ANA result may sometimes be misleading if the cytoplasmic IF is ignored.
